Ryan Dorton

796 total citations
18 papers, 671 citations indexed

About

Ryan Dorton is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Ryan Dorton has authored 18 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Ryan Dorton's work include Cancer Treatment and Pharmacology (5 papers), Folate and B Vitamins Research (4 papers) and Cancer Research and Treatments (3 papers). Ryan Dorton is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Folate and B Vitamins Research (4 papers) and Cancer Research and Treatments (3 papers). Ryan Dorton collaborates with scholars based in United States. Ryan Dorton's co-authors include Joseph A. Reddy, Christopher P. Leamon, Marilynn Vetzel, Elaine Westrick, Iontcho R. Vlahov, Nikki Parker, Paul J. Kleindl, Melissa Nelson, Hari Krishna R. Santhapuram and Le-Cun Xu and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ryan Dorton

18 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan Dorton United States	12	315	219	159	137	130	18	671
George K. Ehrlich United States	9	347 1.1×	99 0.5×	92 0.6×	220 1.6×	78 0.6×	18	664
Giulia Pellizzari United Kingdom	8	253 0.8×	160 0.7×	29 0.2×	72 0.5×	105 0.8×	12	570
Nathalie Harrer Austria	15	428 1.4×	312 1.4×	53 0.3×	32 0.2×	25 0.2×	19	1.0k
David J. Zahavi United States	12	306 1.0×	340 1.6×	15 0.1×	197 1.4×	48 0.4×	13	803
Sheri Nixdorf Australia	15	695 2.2×	182 0.8×	59 0.4×	31 0.2×	37 0.3×	20	914
Jeffery L. Keene United States	16	537 1.7×	109 0.5×	55 0.3×	132 1.0×	31 0.2×	23	1.2k
Sangeeta Bafna United States	10	636 2.0×	290 1.3×	65 0.4×	132 1.0×	25 0.2×	12	896
Richard Beatson United Kingdom	15	765 2.4×	288 1.3×	183 1.2×	167 1.2×	22 0.2×	26	1.1k
Stefan R. Vink Netherlands	11	485 1.5×	103 0.5×	72 0.5×	42 0.3×	33 0.3×	13	618

Countries citing papers authored by Ryan Dorton

Since Specialization

Citations

This map shows the geographic impact of Ryan Dorton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Dorton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Dorton more than expected).

Fields of papers citing papers by Ryan Dorton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Dorton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Dorton. The network helps show where Ryan Dorton may publish in the future.

Co-authorship network of co-authors of Ryan Dorton

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Dorton. A scholar is included among the top collaborators of Ryan Dorton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Dorton. Ryan Dorton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Leamon, Christopher P., Joseph A. Reddy, Ryan Dorton, et al.. (2019). Prostate-Specific Membrane Antigen-Specific Antitumor Activity of a Self-Immolative Tubulysin Conjugate. Bioconjugate Chemistry. 30(6). 1805–1813. 27 indexed citations

Reddy, Joseph A., Ryan Dorton, Melissa Nelson, et al.. (2018). Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic. Scientific Reports. 8(1). 8943–8943. 33 indexed citations

Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2017). Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy. Cancer Chemotherapy and Pharmacology. 79(6). 1151–1160. 10 indexed citations

Guertin, Amy D., Jennifer O’Neil, Alexander Stoeck, et al.. (2016). High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide. Molecular Cancer Therapeutics. 15(8). 1998–2008. 16 indexed citations

Leamon, Christopher P., Iontcho R. Vlahov, Joseph A. Reddy, et al.. (2014). Folate–Vinca Alkaloid Conjugates for Cancer Therapy: A Structure–Activity Relationship. Bioconjugate Chemistry. 25(3). 560–568. 54 indexed citations

Reddy, Joseph A., et al.. (2014). Abstract 832: Pre-clinical development of EC1456: A potent Folate targeted Tubulysin SMDC. Cancer Research. 74(19_Supplement). 832–832. 7 indexed citations

Reddy, Joseph A., et al.. (2014). Rational Combination Therapy of Vintafolide (EC145) with Commonly Used Chemotherapeutic Drugs. Clinical Cancer Research. 20(8). 2104–2114. 23 indexed citations

Reddy, Joseph A., Ryan Dorton, Melissa Nelson, et al.. (2013). Abstract 2145: PSMA-specific anti-tumor activity of the targeted-tubulysin conjugate, EC1169.. Cancer Research. 73(8_Supplement). 2145–2145. 6 indexed citations

Leamon, Christopher P., Joseph A. Reddy, Ryan Dorton, et al.. (2012). Abstract 3622: Predicting response to EC145 therapy using the folate receptor-specific radiodiagnostic imaging agent, 99mTc-EC20. Cancer Research. 72(8_Supplement). 3622–3622. 2 indexed citations

10.

Reddy, Joseph A., et al.. (2011). Abstract 2570: Combination studies of EC145 with approved anti-cancer drugs for ovarian cancer. Cancer Research. 71(8_Supplement). 2570–2570. 1 indexed citations

11.

Leamon, Christopher P., Joseph A. Reddy, Patrick Klein, et al.. (2010). Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications. Journal of Pharmacology and Experimental Therapeutics. 336(2). 336–343. 41 indexed citations

12.

Reddy, Joseph A., Ryan Dorton, Marilynn Vetzel, et al.. (2009). In Vivo Structural Activity and Optimization Studies of Folate−Tubulysin Conjugates. Molecular Pharmaceutics. 6(5). 1518–1525. 54 indexed citations

13.

Leamon, Christopher P., et al.. (2008). Impact of High and Low Folate Diets on Tissue Folate Receptor Levels and Antitumor Responses Toward Folate-Drug Conjugates. Journal of Pharmacology and Experimental Therapeutics. 327(3). 918–925. 56 indexed citations

14.

Leamon, Christopher P., Joseph A. Reddy, Marilynn Vetzel, et al.. (2008). Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue. Cancer Research. 68(23). 9839–9844. 81 indexed citations

15.

Leamon, Christopher P., Joseph A. Reddy, Iontcho R. Vlahov, et al.. (2007). Preclinical Antitumor Activity of a Novel Folate-Targeted Dual Drug Conjugate. Molecular Pharmaceutics. 4(5). 659–667. 89 indexed citations

16.

Reddy, Joseph A., Ryan Dorton, Elaine Westrick, et al.. (2007). Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate. Cancer Research. 67(9). 4434–4442. 145 indexed citations

17.

Reddy, Joseph A., Hari Krishna R. Santhapuram, Elaine Westrick, et al.. (2006). Folate receptor targeted anti-tumor activity of EC-0225, a folate-targeted dual drug conjugate. Cancer Research. 66. 135–135. 1 indexed citations

18.

Dorton, Ryan, et al.. (2006). The Effectiveness of Pond-Breeding Salamanders as Agents of Larval Mosquito Control. Journal of Freshwater Ecology. 21(3). 467–474. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact